Nikko Asset Management Americas, Inc. Pfizer Inc Transaction History

Nikko Asset Management Americas, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $76,534 - $99,410	-2,929 Reduced 4.65%	60,070 $1.73 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $48,135 - $56,265	-1,500 Reduced 2.33%	62,999 $2.09 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $109,082 - $126,205	3,020 Added 4.91%	64,499 $2.37 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $184,305 - $239,939	-4,679 Reduced 7.07%	61,479 $2.51 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $201,151 - $262,581	-4,818 Reduced 6.79%	66,158 $3.39 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $7,876 - $9,615	180 Added 0.25%	70,976 $3.13 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $7.12 Million - $8.45 Million	-153,101 Reduced 68.38%	70,796 $3.7 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $1.23 Million - $1.53 Million	-26,950 Reduced 10.74%	223,897 $11.6 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $4.34 Million - $6.43 Million	-104,927 Reduced 29.49%	250,847 $14.9 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $14 Million - $17.9 Million	355,774 New	355,774 $15.1 Million
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $570,754 - $692,289	-16,558 Closed	0 $0
Q2 2018 Jul 20, 2018	SELL	$32.98 - $35.16 $4.85 Million - $5.17 Million	-147,078 Reduced 89.88%	16,558 $601,000
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $5.5 Million - $6.38 Million	-172,205 Reduced 51.28%	163,636 $5.81 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $10.4 Million - $11.5 Million	335,841	335,841 $12 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.